V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310010559 | 310004631 | 1.7 | 103.9 | Curative (C) | null | 2014-01-31 | Bexarotene | 02 | N | 310018465 | ESHAP |
| 310010560 | 310004634 | 1.6 | 81.8 | Palliative (P) | 2013-09-29 | 2013-10-06 | Bexarotene | null | Y | 310018467 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 310010561 | 310004642 | 1.82 | 74.8 | Palliative (P) | 2019-10-15 | 2019-10-27 | GDP | N | N | 310018478 | GDP |
| 310010562 | 310004645 | 1.68 | 66.8 | Curative (C) | 2014-11-10 | 2015-01-12 | Cyclophosphamide High Dose | 02 | null | 310018484 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 310010563 | 310004650 | 1.7 | 65.699 | Neo-adjuvant (N) | 2015-12-18 | 2016-03-04 | CHOP R - 21 days | N | N | 310018504 | CHOP R |
| 310010564 | 310007984 | 1.72 | 83.4 | Curative (C) | 2017-10-12 | 2017-10-20 | CYCLOPHOSPHAMIDE | N | N | 310018510 | CYCLOPHOSPHAMIDE |
| 310010565 | 310004660 | 0 | 140 | Curative (C) | 2014-08-19 | 2014-08-20 | ESHAP | 02 | N | 310018518 | UKALL2011 |
| 310010566 | 310004663 | 1.85 | 78.3 | null | 2014-09-17 | 2015-01-23 | Cisplatin | Y | N | 310018529 | CISPLATIN |
| 310010567 | 310004665 | 1.58 | null | Curative (C) | 2017-05-26 | 2017-05-26 | Rituximab | 2 | N | 310018530 | RITUXIMAB |
| 310010568 | 310004669 | 1.82 | null | Curative (C) | 2019-07-01 | 2019-07-02 | Cyclophosphamide High Dose | 02 | N | 310018537 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 310010569 | 310004674 | 0 | null | Curative (C) | 2018-09-05 | 2018-09-06 | GDP | N | N | 310018548 | GDP |
| 310010571 | 310004679 | 1.81 | 65.4 | Palliative (P) | null | 2016-07-03 | CHOP R | N | N | 310018568 | CHOP R |
| 310010572 | 310007997 | 1.85 | 95.05 | Curative (C) | 2015-06-20 | 2015-09-06 | CYCLOPHOSPHAMIDE | 02 | N | 310018590 | CYCLOPHOSPHAMIDE |
| 310010573 | 310004693 | 1.79 | 79.4 | Palliative (P) | 2016-07-10 | 2016-08-26 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 2 | N | 310018602 | BEXAROTENE |
| 310010574 | 310008003 | null | null | null | 2018-04-01 | 2018-04-12 | Docetaxel | 2 | N | 310018615 | DOCETAXEL |
| 310010575 | 310004700 | null | null | Palliative (P) | 2017-06-09 | 2016-06-15 | CYCLOPHOSPHAMIDE + FILGRASTIM | 02 | N | 310018629 | CYCLOPHOSPHAMIDE |
| 310010576 | 310004703 | 1.71 | 93.6 | Palliative (P) | 2017-07-29 | 2018-08-29 | Bexarotene | 2 | N | 310018640 | ESHAP |
| 310010577 | 310008009 | null | 90.8 | Curative (C) | null | 2014-04-22 | Cyclophosphamide High Dose | null | null | 310018647 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 310010578 | 310008010 | 1.72 | 57.8 | null | 2019-05-29 | 2019-05-29 | Bexarotene | 02 | N | 310018650 | CARBOPLATIN + ETOPOSIDE |
| 310010579 | 310004711 | 1.81 | 70.5 | Curative (C) | 2014-11-05 | 2015-09-26 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | null | 310018651 | UKALL2011 |
| 310010580 | 310004716 | 1.78 | 93 | Disease modification (D) | 2017-01-29 | 2017-02-25 | ESHAP | N | null | 310018680 | CARBOPLATIN + ETOPOSIDE |
| 310010581 | 310004719 | 1.68 | 97.4 | Palliative (P) | null | 2014-07-19 | ESHAP | N | N | 310018685 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 310010582 | 310004724 | 1.68 | 68.9 | Adjuvant (A) | 2013-06-26 | 2014-07-25 | CYCLOPHOSPHAMIDE + FILGRASTIM | 2 | N | 310018688 | CYCLOPHOSPHAMIDE |
| 310010583 | 310004728 | 1.66 | 59.6 | null | 2017-08-03 | 2018-01-25 | GDP | N | N | 310018697 | GDP |
| 310010584 | 310004730 | 1.67 | 55 | Palliative (P) | 2014-07-12 | 2014-08-02 | Docetaxel 75mg/m2 (21 day) | N | N | 310018701 | DOCETAXEL |
| 310010585 | 310004733 | null | null | Palliative (P) | 2017-01-24 | 2017-01-24 | GDP | 2 | N | 310018713 | GDP |
| 310010586 | 310004736 | 1.81 | 71.8 | Curative (C) | 2016-05-10 | 2016-05-27 | Ipilimumab | null | null | 310018718 | IPILIMUMAB |
| 310010587 | 310009780 | 1.8 | 98.6 | null | 2016-05-20 | 2016-05-21 | DOCETAXEL + GEMCITABINE | N | N | 310018723 | DOCETAXEL + GEMCITABINE |
| 310010588 | 310004741 | 1.73 | 88 | Disease modification (D) | 2016-05-23 | 2016-05-23 | CISPLATIN + RT | N | N | 310018729 | CISPLATIN + RT |
| 310010589 | 310004742 | 1.55 | 72.2 | Palliative (P) | 2018-06-18 | 2018-06-20 | Bexarotene | 2 | N | 310018733 | ESHAP |
| 310010591 | 310008031 | null | 73.2 | Curative (C) | 2016-04-15 | 2016-04-17 | BEVACIZUMAB + CARBO + PACLITAXEL | N | N | 310018736 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 310010592 | 310004749 | 1.56 | 49 | Disease modification (D) | 2018-06-16 | 2018-06-16 | Methotrexate intrathecal | N | N | 310018744 | METHOTREXATE INTRATHECAL |
| 310010593 | 310008034 | 1.58 | 51.7 | Palliative (P) | 2017-04-15 | 2017-04-21 | ALL UKALL2011 Maintenance C1 | N | N | 310018767 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 310010594 | 310004756 | 1.66 | 60.9 | Curative (C) | 2015-04-23 | 2015-11-03 | Ipilimumab | N | N | 310018778 | IPILIMUMAB |
| 310010595 | 310004759 | null | 79.4 | Palliative (P) | null | 2016-12-09 | Rituximab (Maintenance) | N | null | 310018784 | RITUXIMAB |
| 310010596 | 310004765 | 1.69 | 77.4 | Curative (C) | 2018-02-10 | 2018-06-02 | GDP | N | null | 310018818 | GDP |
| 310010597 | 310008045 | 1.69 | null | Curative (C) | 2015-10-16 | 2015-10-16 | Bexarotene | null | null | 310018852 | CARBOPLATIN + ETOPOSIDE |
| 310010598 | 310004771 | 1.64 | 83 | Disease modification (D) | null | 2017-09-08 | Etoposide oral | N | N | 310018858 | ETOPOSIDE |
| 310010599 | 310004775 | 1.47 | 76 | Curative (C) | null | 2018-05-13 | GDP | 2 | N | 310018871 | GDP |
| 310010600 | 310004781 | 1.61 | 57.8 | Disease modification (D) | 2018-05-15 | 2018-05-16 | Cyclophosphamide High Dose | 2 | N | 310018888 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 310010601 | 310004785 | 1.72 | null | Palliative (P) | 2016-06-01 | 2016-06-05 | Methotrexate intrathecal | 02 | N | 310018896 | METHOTREXATE INTRATHECAL |
| 310010602 | 310004787 | 1.77 | 66.5 | Not known (9) | 2015-02-13 | 2015-07-22 | ESHAP | 02 | N | 310018898 | ESHAP |
| 310010603 | 310008055 | 1.71 | 76.9 | Palliative (P) | 2016-12-17 | 2017-03-25 | Bevacizumab + CARBOPLATIN + PACLITAXEL | 02 | N | 310018900 | BEXAROTENE |
| 310010604 | 310008057 | 1.8 | 73 | null | 2015-04-04 | 2015-04-26 | Etoposide oral | N | null | 310018919 | ETOPOSIDE |
| 310010605 | 310004799 | 1.77 | 68.5 | Curative (C) | 2013-03-07 | 2014-03-06 | GDP | N | N | 310018942 | GDP |
| 310010606 | 310004809 | 1.85 | 85.45 | Palliative (P) | 2015-10-21 | 2015-10-23 | ALL UKALL2011 Maintenance A1 | 02 | N | 310018968 | CARBOPLATIN + ETOPOSIDE |
| 310010607 | 310004816 | 1.74 | 96.2 | null | 2015-09-28 | 2015-12-07 | Cyclophosphamide High Dose | N | N | 310018992 | CYCLOPHOSPHAMIDE HIGH DOSE |
| 310010608 | 310004819 | 1.69 | 29.7 | Not known (9) | 2016-11-07 | 2016-11-07 | ESHAP | 2 | null | 310018995 | BEVACIZUMAB + CARBOPLATIN + PACLITAXEL |
| 310010609 | 310008074 | 1.64 | 52.4 | Palliative (P) | 2014-11-25 | 2014-12-01 | DOCETAXEL + GEMCITABINE | 02 | N | 310018998 | CYCLOPHOSPHAMIDE + ETOPOSIDE + PROCARBAZINE |
| 310010610 | 310004825 | 1.74 | 109 | Curative (C) | null | 2017-11-20 | CHOP R - 21 days | N | N | 310019005 | CHOP R |